ArticleBMC cancer2024

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam.

Cam Phuong Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.